Amid Huntington’s disease hopes and failures, Annexon targets new approach


There are no approved therapies for people with Huntington's disease, an inherited neurodegenerative disease that can unset in the 30s and 40s with jerky muscle movements and drastic changes in behavior.

Previous CDC approves omicron-targeting boosters. People could begin receiving the shots next week.
Next Former Pitt pediatric neurosurgeon to join WVU Medicine